Pfizer, Inc. (PFE) Tops Q2 EPS by 1c; Affirms Outlook
Tweet Send to a Friend
Get Alerts PFE Hot Sheet
Price: $29.04 -0.24%
EPS Growth %: -6.9%
Financial Fact:
Selling, informational and administrative expenses: 3.59B
Today's EPS Names:
ANF, DXLG, FL, More
EPS Growth %: -6.9%
Financial Fact:
Selling, informational and administrative expenses: 3.59B
Today's EPS Names:
ANF, DXLG, FL, More
Trade PFE Now!
Pfizer, Inc. (NYSE: PFE) reported Q2 EPS of $0.60, $0.01 better than the analyst estimate of $0.59. Revenue for the quarter came in at $16.98 billion versus the consensus estimate of $16.98 billion.
Affirms outlook.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
Affirms outlook.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
You May Also Be Interested In
- Abercrombie & Fitch Co. (ANF) Misses Q1 EPS by 4c; Guides FY Below Views
- UPDATE: Sears Holding Corp. (SHLD) Reports Q1 Loss of $1.29
- Infoblox (BLOX) Tops Q3 EPS by 5c; Issues Outlook
Create E-mail Alert Related Categories
Earnings, Guidance, Hot Earnings
Login with Facebook
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
